High-quality Cagrilintide Long Half-Life Signaling Widely Used in Pancreatic Receptor Binding Academic Research

Strongly suppresses appetite and reduces calorie intake
Activates the GLP-1 receptor in the hypothalamus, enhances satiety, reduces the desire to eat, and reduces daily total calorie intake at its source, suitable for scientific research related to weight management.

Slows down gastric emptying and prolongs the duration of satiety
Slows down the digestion speed of food in the gastrointestinal tract, prolongs the state of satiety, avoids binge eating, and assists in controlling the frequency and amount of each meal.

Glycemic-dependent regulation, stable blood sugar control
Only promotes insulin secretion and inhibits glucagon release when blood sugar rises, precisely and steadily controls blood sugar, suitable for scientific research experiments related to type 2 diabetes.

Long-lasting effect, enhances convenience of use
After structural modification, the half-life is approximately 7 days, providing long-lasting and stable effects, reducing the frequency of administration, and suitable for scientific research related to long-acting peptide drugs.

Improves metabolic-related indicators
Assists in improving insulin resistance, regulating lipid levels, and has reference value for scientific research on metabolic syndrome related to obesity.

Hong Kong Bosen Peptide Research & Development Co., Ltd. is a world-leading manufacturer and supplier of peptides and pharmaceutical raw materials, specializing in the chemical industry.

Our main products include peptide products and pharmaceutical raw materials. We possess strong research and development capabilities, exquisite synthesis technologies, and advanced quality control methods. We actively carry out joint ventures and cooperation with major enterprises and manufacturers, and adhere to the concept of industrial development to serve society and users. We always adhere to market demand orientation, and continuously develop new high-tech chemical products and pharmaceutical intermediates.

I am fully confident in the quality of our products, and many overseas customers have spoken highly of them after receiving the goods. Our products are of excellent quality, and we solemnly promise door-to-door delivery service worldwide. We provide high-quality after-sales service aimed at customer satisfaction.

Cas No. 2023788-19-2 SDF

Formula C225H348N48O68 M.Wt 4813.45

Solubility Soluble in DMSO Storage Store at -20°C

General tips For obtaining a higher solubility, please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Stock solution can be stored below -20℃ for several months.

Shipping Condition Secure Appearance: Powder Purity: >99% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide. Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2

 Was established in 2019. It mainly deals in peptide products, synthetic peptide amino acids, beauty and slimming products, and beauty freckle removal cosmetic raw materials. It has strong R&D capabilities, superb synthesis technology, and advanced quality control methods. It effectively promotes joint ventures with major companies and manufacturers, and serves the society and users with the concept of industrial development. It always adheres to market demand-oriented, continuously synthesizing new high-tech freckle and wrinkle removal beauty peptide products, which are mainly exported to the United States, Europe, South Africa, Nigeria and other countries and regions. It has rich export experience and ensures transportation safety.